The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
This is a very significant event for Ceregene. Previous studies, with drug treatment, on treatment for parkinsons have shown that the placebo effect only lasts for three months. The symptoms of Parkinson's increase 5-10% per year( as part of the natural progression of the disorder). ...
Genetic screening for disease states, cancer, cancer progression and other metabolic conditions often promise much, but fail to deliver the clinical sensitivity and specificity of traditional diagnostic tests. The relatively low predictive value and nominal regulation of...
A new rapid test for chlamydia trachoma, the world's most prevalent sexually transmitted bacterial disease will improve the efficiency of existing screening programs and make testing accessible to developing countries that often do not have the healthcare infrastructure to support diagnosis and treatment....
For too long Allergan has monopolized the therapeutic and cosmetic market of botulinum toxin type A, and has taken full advantage of that monopoly by raising the price of Botox almost biannually. Reloxin studies are very favorable when compared to Botox, and may even surpass it in one or two aspects....
1. If Members of Congress and those running for president in 2008 do not recognize that this nation is in a health care crisis, we have only ourselves to blame---we put them into office to better our lives, and they are not doing the job at all, particlarly when it comes to ensuring health care services...
Two recent articles in the 10/23/07 Wall Street Journal indicate that recent media attention on "superbugs", such as MRSA and others are resulting in legislation on the state and federal level. This legislation is likely to accelerate the unanticipated rate of growth for certain infection...
A recent study of 10,154 women, published this week in the New England of Journal of Medicine, found that using the HPV (human papilloma virus) DNA test to screen for cervical cancer was twice as accurate as the traditional Pap smear. The sensitivity of the molecular...
A recent study by ConsumerLab.com suggests that some generic versions of pharmaceutical products may not be bioequivalent to their brand name counterparts. The difference seems to be in the release rates for extended-release (ER) dosage forms as determined by in vitro ("test tube") analysis of...